Financing the Fight Against Antimicrobial Resistance in Asia

Session overview

Understand antimicrobial resistance as both a critical health crisis and an underappreciated investment opportunity. Learn why market failures have created financing gaps in clinical development, diagnostics, and healthcare infrastructure, and explore innovative financing models that enable public-private-philanthropic collaboration to combat this growing threat.

Target audience

Healthcare-focused impact investors and asset owners, pharmaceutical strategists, foundations, development finance programme managers, healthcare policymakers

Format

Half-day seminar | In-person or virtual

Key topics

• AMR crisis overview: health, economic, and development impacts in Asia
• Multi-sectoral drivers: healthcare, agriculture, environment
• Mapping the financing gaps across R&D and health systems
• Innovative financing mechanisms: push/pull incentives, subscription models
• Collaborative investment strategies and partnership opportunities

Customised learning solutions

Curated programming to address your organisation's specific needs, including:

• Duration: From 2-hour executive briefings to full-day workshops
• Format: In-person workshops, virtual or hybrid
• Focus: Sector-specific deep-dives, geography-specific content, or role-specific tracks

Our training programmes feature:

• Interactive case studies and real-world applications
• Practitioner and investor perspectives
• Practical frameworks and tools for implementation
• Access to our research and expert networks

Get in touch

Interested in bringing these programmes to your organistion or joining a cohort session? Contact us to discuss your learning objectives and co-design a programme that meets your needs.